An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands

Journal of Medical Virology

Volumn 77, Issue 3, 2005, Pages 360-366

  Tjon, G M S ^a   Gotz H ^b   Koek, A G ^a   De Zwart, O ^b   Mertens, P L J M ^b   Coutinho, R A ^a,c   Bruisten, S M ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b Public Health Service of the Rotterdam Region   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Phylogenetic analysis; Public health; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD; DRUG USE; EPIDEMIC; FECES; FEMALE; GENOTYPE; HEPATITIS A; HEPATITIS A VIRUS; HOMELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; VACCINATION; VIRUS GENOME;

DISEASE OUTBREAKS; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HOMELESS PERSONS; HUMANS; IMMUNIZATION PROGRAMS; MOLECULAR SEQUENCE DATA; NETHERLANDS; PHYLOGENY; PUBLIC HEALTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS; VACCINATION;

HEPATITIS A VIRUS;

EID: 25844510156     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20464     Document Type: Article

References (27)

1. Bruisten SM, Steenbergen van JE, Pijl AS, Niesters HGM, Doornum van GJJ, Coutinho RA. 2001. Molecular epidemiology of hepatitis A virus in Amsterdam. J Med Virol 63:88-95.
2. Chudy M, Stahl-Hennig C, Berger A, Nubling CM, Hunsmann G, Rabenau HF, Lower J. 2002. Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates. J Infect Dis 185:1170-1173.
3. Crowcroft NS. 2003. Hepatitis A virus infections in injecting drug users. Commun Dis Public Health 6:82-84.
4. Gust ID, Coulepis AG, Feinstone SM, Locarnini SA, Moritsugu Y, Najera R, Siegl G. 1983. Taxonomic classification of hepatitis A virus. Intervirology 20:1-7.
5. Hall TA. 1999. BioEdit: A user-friendly biological sequence alignment editor and analysis. Ref Type: Computer Program.
6. Kumar S, Tamura K, Jakobsen IB, Nei M. 2001. MEGA2: Molecular evolutionary genetics analysis software, Arizona State University, Tempe, Arizona, USA. Ref Type: Computer Program.
7. Leino T, Leinikki P, Hyypia T, Ristola M, Suni J, Sutinen J, Holopainen A, Haikala O, Valle M, Rostila T. 1997. Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis 29:213-216.
8. Lemon SM, Binn LN. 1983. Serum neutralizing antibody response to hepatitis A virus. J Infect Dis 148:1033-1039.
9. Lu L, Ching KZ, de Paula VS, Nakano T, Siegl G, Weitz M, Robertson BH. 2004. Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J Gen Virol 85: 2943-2952.
10. MacGregor A, Kornitschuk M, Hurrell JG, Lehmann NI, Coulepis AG, Locarnini SA, Gust ID. 1983. Monoclonal antibodies against hepatitis A virus. J Clin Microbiol 18:1237-1243.
11. Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell RH. 1994. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med 120:1-7.
12. Markku Kuusi, Pekka Nuorti, Timo Rostila, Camilla Jokinen. 2003. Hepatitis A infections in intravenous drug users, Finland, 2002. Eurosurveillance Weekly 7.
13. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. 1996. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 150:733-739.
14. O'Donovan D, Cooke RP, Joce R, Eastbury A, Waite J, Stene-Johansen K. 2001. An outbreak of hepatitis A amongst injecting drug users. Epidemiol Infect 127:469-473.
15. Perrett K, Granerod J, Crowcroft N, Carlisle R. 2003. Changing epidemiology of hepatitis A: Should we be doing more to vaccinate injecting drug users? Commun Dis Public Health 6:97-100.
16. Robertson BH. 1991. Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis 163:286-292.
17. Robertson BH, Jansen RW, Khanna B, Totsuka A, Nainan OV, Siegl G, Widell A, Margolis HS, Isomura S, Ito K. 1992. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73:1365-1377.
18. Roy K, Howie H, Sweeney C, Parry J, Molyneaux P, Goldberg D, Taylor A. 2004. Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: A case-control study. J Viral Hepat 11:277-282.
19. Stene-Johansen K, Skaug K, Blystad H, Grinde B. 1998. A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis 30:35-38.
20. Stene-Johansen K, Skaug K, Blystad H. 1999. Surveillance of hepatitis A by molecular epidemiologic studies. Tidsskr Nor Laegeforen 119: 3725-3729.
21. Syed NA, Hearing SD, Shaw IS, Probert CS, Brooklyn TN, Caul EO, Barry RE, Sarangi J. 2003. Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: Control by a targeted vaccination programme and possible parenteral transmission. Eur J Gastroenterol Hepatol 15:901-906.
22. Tallo T, Norder H, Tefanova V, Ott K, Ustina V, Prukk T, Solomonova O, Schmidt J, Zilmer K, Priimagi L, Krispin T, Magnius LO. 2003. Sequential changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 70:187-193.
23. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den HS, Conyn-Van Spaendonck MA. 2000. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: A population-based survey. Epidemiol Infect 124:459-466.
24. Tjon GM, Wijkmans CJ, Coutinho RA, Koek AG, Van den Hoek JA, Leenders AC, Schneeberger PM, Bruisten SM. 2005. Molecular epidemiology of hepatitis A in Noord-Brabant, The Netherlands. J Clin Virol 32:128-136.
25. Van Der Eerden LJ, Bosman A, Van Duynhoven YT. 2004. Surveillance of hepatitis A in The Netherlands 1993-2002. Ned Tijdschr Geneeskd 148:1390-1394.
26. van Steenbergen JE, Tjon G, Van Den Hoek A, Koek A, Coutinho RA, Bruisten SM. 2004. Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002. J Infect Dis JID-0413675 189:471-482.
27. Werzberger A, Mensch B, Nalin DR, Kuter BJ. 2002. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA. Vaccine 20: 1699-1701.